Utama › Penyakit Parkinson › Maryland
Kajian klinikal Penyakit Parkinson di Maryland
15 kajian untuk Penyakit Parkinson sedang mencari peserta di lokasi di Maryland.
Bandar di Maryland
Teks kajian rasmi (Bahasa Inggeris)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of Maryland, Baltimore
Mengambil pesertaFasa 2
Umur 40 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06680830Evaluation and Treatment of Neurosurgical Disorders
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 4 hingga 99 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT00060541Deep Brain Stimulation Therapy in Movement Disorders
- National Institutes of Health Clinical Center, Bethesda
Mengambil peserta
Umur 18 hingga 100 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT02119611PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 99 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT04396873Natural History Protocol for Movement Disorders
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 2 hingga 100 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT05413291A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #043, Baltimore
- Vima Site #007, Olney
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07804615Parkinson's Foundation PD GENEration Genetic Registry
- Johns Hopkins, Baltimore
- University of Maryland, College Park
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- MedStar Montgomery Medical Center, Olney
Mengambil pesertaKajian pemerhatian
Umur 45 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07330258Deep Brain Stimulation Surgery for Movement Disorders
- National Institutes of Health Clinical Center, Bethesda
Mengambil peserta
Umur 18 hingga 99 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT01581580A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Johns Hopkins Hospital - Neurology, Baltimore
Mengambil pesertaFasa 3
Umur 45 hingga 75 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Johns Hopkins University, Baltimore
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 30 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT04477785Effects of RAS on Gait in PD Patients With DBS
- Johns Hopkins School of Medicine, Baltimore
Mengambil peserta
Umur 18 hingga 89 · Semua jantina · Dikemas kini 6 Mei 2026 · NCT05763732First-in-Human Single and Multiple Dose of HL-400
- Pharmaron CPC, Inc., Baltimore
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 17 Apr 2026 · NCT06997484A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
- University of Maryland, Baltimore, Baltimore
Mengambil pesertaKajian pemerhatian
Umur 30 hingga 99 · Semua jantina · Dikemas kini 20 Mac 2026 · NCT05539196Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
- University of Maryland, Baltimore
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Feb 2026 · NCT06719583Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.